| Yesterday | ||||
Catch up on today's… Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Generac (GNRC) upgraded to Outperform from Perform at Oppenheimer analyst Christopher Glynn saying he sees "solid" prospects for revenue upside and improving visibility to long-term scaling. 2. BioMarin (BMRN) upgraded to Outperform from Sector Perform at RBC Capital with analyst Kennen Mackay saying he believes that the stock is undervalued ahead of the regulatory decisions on ValRox and the possibility of the company's first "product genericization." 3. STMicroelectronics (STM) upgraded to Neutral from Underperform at Baird with analyst Tristan Gerra saying the current semiconductor cycle trough is "much shallower" than previously expected. 4. DaVita (DVA) upgraded to Buy from Neutral at Goldman Sachs with analyst Stephen Tanal saying beginning in 2021, people with end stage renal disease will be able to enroll in any Medicare Advantage plan, marking a rule change that carries implications across the healthcare services ecosystem. 5. Unilever (UN, UL) upgraded to Buy from Hold at Jefferies. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here. | ||||
Oppenheimer analyst… Oppenheimer analyst Christopher Glynn upgraded Generac Holdings to Outperform from Perform with a $125 price target. The analyst sees "solid" prospects for revenue upside and improving visibility to long-term scaling. The sustained strength in core standby demand fundamentals, coupled with emergence of the California market and launch into "clean energy," supports an estimated 11% 2020 residential growth, Glynn tells investors in a research note. | ||||
Oppenheimer analyst… Oppenheimer analyst Christopher Glynn upgraded Generac to Outperform from Perform with a $125 price target. | ||||
| Over a month ago | ||||
Meeting to be held in New… Meeting to be held in New York on December 16 hosted by Roth Capital. | ||||
Meeting to be held in New… Meeting to be held in New York on December 16 hosted by Roth Capital. | ||||
Check out today's top… | |
Northcoast analyst Tom… Northcoast analyst Tom Hayes raised his price target for Generac to $118 from $93 saying the company's Q3 results surpassed expectations. The analyst remains impressed with the Generac's "strong sales execution" in both its core and newer markets. Hayes continues to see "significant growth opportunities" for the company and keeps a Buy rating on the shares. | |
BofA/Merrill analyst Ross… BofA/Merrill analyst Ross Gilardi downgraded Generac to Neutral from Buy with a $108 price target. The analyst notes that expectations for the company's growth are "very high" due to potential upside from the California fire-related penetration opportunity, but it is no "longer a secret." Gilardi adds that while Generac had a decent Q3, parts of its Commercial and Industrial business will weigh on growth for the next year and reduce the upside as peak forest fire / hurricane season subsides in Q4. | |
BofA/Merrill downgraded… BofA/Merrill downgraded Generac to Neutral from Buy. | |
Raises net income margin… Raises net income margin view, before deducting for noncontrolling interests, to 11.5% from 11.0% for the full-year 2019. |